Cargando…
Raloxifene and n-Acetylcysteine Ameliorate TGF-Signalling in Fibroblasts from Patients with Recessive Dominant Epidermolysis Bullosa
Recessive dystrophic epidermolysis bullosa (RDEB) is a severe skin disease caused by mutation of the COL7A1 gene. RDEB is associated with high levels of TGF-β1, which is likely to be involved in the fibrosis that develops in this disease. Endoglin (CD105) is a type III coreceptor for TGF-β1 and its...
Autores principales: | Aguado, Tania, García, Marta, García, Adela, Ferrer-Mayorga, Gemma, Martínez-Santamaría, Lucía, del Río, Marcela, Botella, Luisa-María, Sánchez-Puelles, José-María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565802/ https://www.ncbi.nlm.nih.gov/pubmed/32947957 http://dx.doi.org/10.3390/cells9092108 |
Ejemplares similares
-
A prevalent mutation with founder effect in Spanish Recessive Dystrophic Epidermolysis Bullosa families
por: Cuadrado-Corrales, Natividad, et al.
Publicado: (2010) -
TGFβ-signaling in Squamous Cell Carcinoma Occurring in Recessive Dystrophic Epidermolysis Bullosa
por: Knaup, Julia, et al.
Publicado: (2011) -
Peripheral neuro-immune pathology in recessive dystrophic epidermolysis bullosa
por: Mack, Madison, et al.
Publicado: (2014) -
Dominance of Methicillin-Resistant Staphylococcus aureus in a Japanese Infant with Recessive Dystrophic Epidermolysis Bullosa
por: Kondo, Makoto, et al.
Publicado: (2021) -
Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing
por: Bonafont, Jose, et al.
Publicado: (2021)